Coronavirus disease 2019-Historical context, virology, pathogenesis, immunotherapy, and vaccine development
- PMID: 32755425
- PMCID: PMC8641599
- DOI: 10.1080/21645515.2020.1787068
Coronavirus disease 2019-Historical context, virology, pathogenesis, immunotherapy, and vaccine development
Abstract
The current Coronavirus Disease 2019 (COVID-19) pandemic is causing great alarm around the world. The pathogen for COVID-19 - severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - is the seventh known coronavirus to cause pneumonia in humans. While much remains unknown about SARS-CoV-2, physicians and researchers have begun to publish relevant findings, and much evidence is available on coronaviruses previously circulating in human and animal populations. In this review, we situate COVID-19 in its context as a transboundary viral disease, and provide a comprehensive discussion focused on the discovery, spread, virology, pathogenesis, and clinical features of this disease, its causative coronaviral pathogen, and approaches to combating the disease through immunotherapies and other treatments and vaccine development. An epidemiological survey revealed a potentially large number of asymptomatic SARS-CoV-2 carriers within the population, which may hamper efforts against COVID-19. Finally, we emphasize that vaccines against SARS-CoV-2, which may be developed by 2021, will be essential for prevention of COVID-19.
Keywords: Human coronavirus; origin; pathogenesis; public health; respiratory viruses; sars-CoV-2.
Conflict of interest statement
We declare no competing interests.
Figures
Similar articles
-
Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19.Hum Vaccin Immunother. 2020 Dec 1;16(12):3055-3060. doi: 10.1080/21645515.2020.1796425. Epub 2020 Aug 26. Hum Vaccin Immunother. 2020. PMID: 32845733 Free PMC article. Review.
-
SARS-CoV-2 reinfection and implications for vaccine development.Hum Vaccin Immunother. 2020 Dec 1;16(12):3061-3073. doi: 10.1080/21645515.2020.1830683. Hum Vaccin Immunother. 2020. PMID: 33393854 Free PMC article. Review.
-
COVID-19 vaccines: The status and perspectives in delivery points of view.Adv Drug Deliv Rev. 2021 Mar;170:1-25. doi: 10.1016/j.addr.2020.12.011. Epub 2020 Dec 24. Adv Drug Deliv Rev. 2021. PMID: 33359141 Free PMC article. Review.
-
Current perspective on diagnosis, epidemiological assessment, prevention strategies, and potential therapeutic interventions for severe acute respiratory infections caused by 2019 novel coronavirus (SARS-CoV-2).Hum Vaccin Immunother. 2020 Dec 1;16(12):3001-3010. doi: 10.1080/21645515.2020.1794684. Epub 2020 Sep 3. Hum Vaccin Immunother. 2020. PMID: 32881628 Free PMC article. Review.
-
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E. J Biol Regul Homeost Agents. 2021. PMID: 33377359
Cited by
-
Mix-and-match COVID-19 vaccines trigger high antibody response after the third dose vaccine in Moroccan health care workers.Vaccine X. 2023 Aug;14:100288. doi: 10.1016/j.jvacx.2023.100288. Epub 2023 Mar 25. Vaccine X. 2023. PMID: 37008956 Free PMC article.
-
Evaluation of SARS-CoV-2 antigen-based rapid diagnostic kits in Pakistan: formulation of COVID-19 national testing strategy.Virol J. 2021 Feb 13;18(1):34. doi: 10.1186/s12985-021-01505-3. Virol J. 2021. PMID: 33581714 Free PMC article.
-
Vaccination and Antiviral Treatment Reduce the Time to Negative SARS-CoV-2 Swab: A Real-Life Study.Viruses. 2023 Oct 30;15(11):2180. doi: 10.3390/v15112180. Viruses. 2023. PMID: 38005858 Free PMC article.
-
Plant-derived compounds effectively inhibit the main protease of SARS-CoV-2: An in silico approach.PLoS One. 2022 Aug 23;17(8):e0273341. doi: 10.1371/journal.pone.0273341. eCollection 2022. PLoS One. 2022. PMID: 35998194 Free PMC article.
-
Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination.Vaccines (Basel). 2021 Aug 16;9(8):910. doi: 10.3390/vaccines9080910. Vaccines (Basel). 2021. PMID: 34452035 Free PMC article. Review.
References
-
- WHO . Coronavirus disease (COVID-19) outbreak. Situation reports. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... [accessed on 19 May 2020].
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous